Dicarboxylic acids and correlated compounds as a measure of red blood cell quality
US10816557B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 10, 2015 |
| Grant date | Oct 27, 2020 |
| Priority date | — |
| Expiry date | Sep 6, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for testing a red blood cell (RBC) unit for release for transfusion into a subject are described. The methods allow management of the blood supply by assessing the viability of an RBC unit by its levels of dicarboxylic fatty acids (DFA). The methods include testing an RBC sample from an RBC unit for levels of DFA and discarding the RBC unit or releasing the RBC unit for transfusion based on the results.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.